Paris Descartes University's gene therapy developer has raised $42.1m altogether following a series B featuring existing investors including Inserm Transfert Initiative.

Samsung, SIG and OP Financial contributed to $144m in funding, raised across two rounds, for digital health technology producer Zhiyun Health.

Corporate-backed healthcare app developer Finc Technologies has raised $46.1m in fresh funding that will fund marketing and business development, bringing its overall financing to more than $138m.

Darren Carroll has emerged from a short sabbatical following 22 years in corporate venturing for Eli Lilly by joining Polaris Partners.

LG CNS and Kakao Ventures chipped into a $25.7m round for the medical imaging-analysis platform developer, boosting its overall funding to $46m.

Weizmann Institute of Science has become the latest academic research institution to join forces with Deerfield Management for a drug discovery program.

ETH Zurich's portfolio attracted a record $649m in funding last year, and the university also spawned more businesses year-on-year.

Henry Crown and Company’s investment affiliate CVF returned once again to back an $85m round for root canal treatment developer Sonendo.

Today’s deal net captures the smaller investments from across the university innovation ecosystem over the past two weeks.

Chinese Academy of Sciences-owned Cash Capital was among the investors in precision cancer screening business MyGene Diagnostics' second funding round.